(Q43923791)

English

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania

scientific article published on September 16, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Shahin Akhondzadeh

13

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

object named as

Bahman Salehi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843556

13 July 2024

4

object named as

Bahman Salehi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843556

13 July 2024

Gholam Reza Esfandiari

7

object named as

Gholam-Reza Esfandiari

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843556

13 July 2024

Gholam Reza Esfandiari

8

object named as

Gholam-Reza Esfandiari

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843556

13 July 2024

author name string

Zohreh Amrollahi

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Farzin Rezaei

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Amir-Hossein Modabbernia

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Azad Maroufi

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Gholam-Reza Esfandiari

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mehrangiz Naderi

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Fariba Ghebleh

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Seyed-Ali Ahmadi-Abhari

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Majid Sadeghi

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Mina Tabrizi

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20843556

13 July 2024

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0165032710005495?httpAccept=text/xml

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

https://api.elsevier.com/content/article/PII:S0165032710005495?httpAccept=text/plain

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Journal of Affective Disorders

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1-3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

327-331

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Is it time to have another look at lithium maintenance therapy in bipolar disorder?

1

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial

2

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial

3

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania

5

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania

6

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder

7

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

A rating scale for depression

8

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

The positive and negative syndrome scale (PANSS) for schizophrenia

9

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder

10

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen

11

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

A rating scale for mania: reliability, validity and sensitivity

12

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder

13

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

14

1 reference

10.1016/J.JAD.2010.08.015

https://api.crossref.org/works/10.1016/J.JAD.2010.08.015

13 July 2024

Identifiers

10.1016/J.JAD.2010.08.015

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43923791&oldid=2203425835"